You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HRR

Showing 1 - 25 of 288
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

HRR as a Novel Biomarker in Sjögren's Syndrome

Completed
  • Sjögren's Syndrome
  • blood sample analysis
  • Tianjin, Tianjin, China
    Tianjin Eye Hospital
Nov 30, 2022

Homologous Recombination-related Genesmutationsand HRD in Breast

Not yet recruiting
  • Breast Cancer
  • HER2-low Breast Cancer
  • Standard Management
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 18, 2022

Overweight Trial in Grand Forks (50% heart rate reserve (HRR) low intensity exercise, 75% HRR moderate intensity exercise,

Recruiting
  • Overweight
  • 50% heart rate reserve (HRR) low intensity exercise
  • +2 more
  • Grand Forks, North Dakota
    USDA Grand Forks Human Nutrition Research Center
Oct 9, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Olaparib)

Recruiting
  • Prostate Cancer
  • +2 more
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 20, 2022

HRR Prevalence in LatAm PROSPECT Study

Completed
  • Castration-resistant Prostate Cancer
    • Ciudad Autónoma de Buenos Aires, Argentina
    • +10 more
    Apr 19, 2022

    Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Olaparib tablet
    • +2 more
    • (no location specified)
    Dec 7, 2021

    Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)

    Recruiting
    • Lung Cancer
    • Mesothelioma
    • niraparib and dostarlimab
    • Orbassano, Turin, Italy
      AOU San Luigi- Department of Oncology
    Oct 6, 2021

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

    Not yet recruiting
    • Gastric Cancer Stage IV
    • Seoul, Korea, Republic of
      Severance Hospital
    Aug 29, 2021

    HER2-negative Breast Cancer, Gastric Adenocarcinoma, Cholangiocarcinoma Trial in Beijing (Niraparib, Anlotinib)

    Not yet recruiting
    • HER2-negative Breast Cancer
    • +3 more
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Feb 18, 2021

    HRR-related Genes Mutations and Prognosis in Metastatic

    Completed
    • Prostatic Neoplasms
      • Nagoya, Aichi, Japan
      • +25 more
      Nov 30, 2021

      Ovarian Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Epithelial Trial in Wuhan (CRS+HIPEC, CRS alone)

      Recruiting
      • Ovarian Cancer
      • +4 more
      • CRS+HIPEC
      • CRS alone
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Sep 4, 2020

      Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency Trial in Korea, Republic of

      Recruiting
      • Solid Tumors
      • +2 more
      • Goyang, Gyeongggi-do, Korea, Republic of
      • +17 more
      Jan 20, 2022

      Interstitial Lung Disease Trial in Phoenix (Trans Sodium Crocetinate, Placebo)

      Terminated
      • Interstitial Lung Disease
      • Trans Sodium Crocetinate
      • Placebo
      • Phoenix, Arizona
        Pulmonary Associates, P.A.
      Aug 8, 2022

      mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

      Not yet recruiting
      • mCRPC
      • Binghamton, New York
      • +5 more
      Dec 14, 2021

      Anterior Cruciate Ligament Tear Trial in Detroit (ACL Reconstruction with Hybrid Remnant Repair, ACL Reconstruction without

      Recruiting
      • Anterior Cruciate Ligament Tear
      • ACL Reconstruction with Hybrid Remnant Repair
      • ACL Reconstruction without Hybrid Remnant Repair
      • Detroit, Michigan
        Henry Ford Hospital
      Aug 7, 2022

      Can BFR Cycling Augment Strength and VO2peak Trial in Newberg (BFR cycling, Cycling without BFR)

      Recruiting
      • Can BFR Cycling Augment Strength and VO2peak
      • BFR cycling
      • Cycling without BFR
      • Newberg, Oregon
      • +1 more
      Apr 22, 2022

      Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

      Active, not recruiting
      Has Results
      • Metastatic Triple Negative Breast Cancer
      • Olaparib Continuous (28-Day cycle) 300 mg BD.
      • +2 more
      • Birmingham, Alabama
      • +140 more
      Nov 17, 2022

      BRCA or HRR+ Mutated Ovarian Cancer Patients Trial in Worldwide (Olaparib)

      Completed
      Has Results
      • BRCA or HRR+ Mutated Ovarian Cancer Patients
      • Plovdiv, Bulgaria
      • +58 more
      Dec 21, 2021

      Breast Cancer Trial in Spain (Olaparib)

      Terminated
      • Breast Cancer
      • Barcelona, Spain
      • +7 more
      Jan 18, 2023

      HIV, Arterial Stiffness, Cognitive Dysfunction Trial in Birmingham (High-Intensity Interval Training, Continuous Moderate

      Not yet recruiting
      • HIV
      • +2 more
      • High-Intensity Interval Training
      • Continuous Moderate Exercise
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jul 27, 2023

      Heart Rate Recovery as a Peri-operative Risk Measure

      Recruiting
      • Peri-operative Injury
        • Clydebank, United Kingdom
        • +3 more
        Sep 27, 2022

        The Intelligent Cardiopulmonary Rehabilitation System: A

        Completed
        • Cardiac Rehabilitation
        • ICRS
        • Taipei, Taiwan
          Wan Fan Hospital
        Aug 3, 2021

        Testing Circulating Tumour DNA for Homologous Recombination Gene

        Recruiting
        • Circulating Tumor DNA
        • Metastatic Prostate Cancer
        • Blood sample
        • Urine sample
        • Tours, France
          University hospital
        Sep 6, 2022